Tenet Healthcare Corporation (THC) currently holds an average brokerage recommendation (ABR) of 1.16, indicating a strong buy to buy consensus, based on 19 recommendations from various brokerage firms. Of these, 17 are classified as Strong Buy, accounting for approximately 89.5% of the total recommendations.
Additionally, the Zacks Consensus Estimate for Tenet’s earnings has risen by 6.1% over the past month, now projected at $11.39 for the current year. This favorable revision has also led to a Zacks Rank of #1 (Strong Buy) for the company, suggesting positive investment sentiment moving forward.
Investors are advised to use these ratings in conjunction with their own analysis, as broker recommendations may exhibit bias due to firms’ vested interests in the stocks they cover.
5 Stocks Our Experts Predict Could Double In the Next Year
By submitting your email, you'll also get a free pivot & flow membership. A free daily market overview. You can unsubscribe at any time.
